I don't say too much here because as Dirty Harry says, "A man's got to know his limitations" but I remember from years ago, maybe earlyish 2020 that if all else failed getting Zantrene approved as a chemotherapeutic for AML only would be worth $12 per share. Now the SOI haven't increased that much since then so that has always been the minimum figure I would consider based on the company's prospects at the time. Obviously I would be guided by the board. Hopefully some others remember this maybe other long termers like Titans, II, John, LT or Eddy to name a few. I'm still very confident that we'll get a transaction and for me the opportunity cost is not being in RAC when that time comes. My dodgy memory and opinion only. Have a great 2023 everyone.
- Forums
- ASX - By Stock
- Ann: Letter to Shareholders, Notice of Meeting & Proxy Form
I don't say too much here because as Dirty Harry says, "A...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.75 |
Change
-0.075(4.12%) |
Mkt cap ! $303.9M |
Open | High | Low | Value | Volume |
$1.84 | $1.84 | $1.74 | $361.4K | 204.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2114 | $1.74 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.75 | 1250 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 390 | 1.740 |
1 | 924 | 1.735 |
1 | 959 | 1.730 |
2 | 10990 | 1.725 |
2 | 6000 | 1.720 |
Price($) | Vol. | No. |
---|---|---|
1.750 | 1250 | 2 |
1.755 | 196 | 1 |
1.760 | 1609 | 2 |
1.770 | 4413 | 2 |
1.775 | 1793 | 2 |
Last trade - 14.47pm 02/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |